MIM
TMDX icon

MetLife Investment Management’s Transmedics TMDX Stock Holding History

MetLife Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Sell
18,327
-193
-1% -$25.2K 0.01% 1107
2025
Q4 		$2.25M Sell
18,520
-838
-4% -$105K 0.01% 1025
2025
Q3 		$2.17M Sell
19,358
-406
-2% -$47.5K 0.01% 1048
2025
Q2 		$2.65M Buy
19,764
+401
+2% +$44K 0.02% 863
2025
Q1 		$1.3M Sell
19,363
-277
-1% -$19.1K 0.01% 1234
2024
Q4 		$1.22M Buy
19,640
+1,116
+6% +$104K 0.01% 1313
2024
Q3 		$2.91M Hold
18,524
– – 0.02% 818
2024
Q2 		$2.79M Buy
18,524
+1,976
+12% +$237K 0.02% 817
2024
Q1 		$1.22M Hold
16,548
– – 0.01% 1187
2023
Q4 		$1.31M Hold
16,548
– – 0.01% 1164
2023
Q3 		$906K Hold
16,548
– – 0.01% 1280
2023
Q2 		$1.39M Buy
16,548
+358
+2% +$27.4K 0.01% 1088
2023
Q1 		$1.23M Hold
16,190
– – 0.01% 1125
2022
Q4 		$999K Hold
16,190
– – 0.01% 1213
2022
Q3 		$676K Buy
16,190
+1,967
+14% +$85.5K 0.01% 1420
2022
Q2 		$447K Sell
14,223
-1,338
-9% -$35.7K ﹤0.01% 1740
2022
Q1 		$419K Buy
15,561
+6,307
+68% +$113K ﹤0.01% 1882
2021
Q4 		$177K Hold
9,254
– – ﹤0.01% 2124
2021
Q3 		$306K Sell
9,254
-2,965
-24% -$90.6K ﹤0.01% 1813
2021
Q2 		$405K Hold
12,219
– – ﹤0.01% 1696
2021
Q1 		$507K Hold
12,219
– – ﹤0.01% 1514
2020
Q4 		$243K Hold
12,219
– – ﹤0.01% 1867
2020
Q3 		$168K Hold
12,219
– – ﹤0.01% 1958
2020
Q2 		$219K Buy
12,219
+4,842
+66% +$75.7K ﹤0.01% 1857
2020
Q1 		$89.1K Hold
7,377
– – ﹤0.01% 2135
2019
Q4 		$140K Buy
+7,377
New +$135K ﹤0.01% 2160

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's TMDX Position: Q1 2026 in Review

MetLife Investment Management reduced its Transmedics (TMDX) stake by 1% in Q1 2026, selling an estimated $25.2K and leaving 18,327 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #1107.

MetLife Investment Management first reported a position in TMDX in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.91M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • MetLife Investment Management held 18,327 shares of Transmedics worth $1.82M as of Q1 2026.
  • MetLife Investment Management sold 193 Transmedics shares in Q1 2026, an estimated $25.2K.
  • Transmedics made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1107 holding.
  • MetLife Investment Management first reported a position in Transmedics in Q4 2019 and has held it in 26 quarters since.
  • MetLife Investment Management's Transmedics position peaked at $2.91M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.